The AI machine learning model to detect a disorder that typically affects babies who are born early was developed by a team of University of Rochester researchers.

HCW11-040 is a pembrolizumab-based fusion immunotherapeutic that activates immune cells and eliminates high-oxygen induced senescent cells. BPD is a rare pediatric disease affecti ...

Please provide your email address to receive an email when new articles are posted on . There are no approved prevention drugs for bronchopulmonary dysplasia in extremely premature infants. A global ...

Extremely preterm newborns who weigh less than 3.3 pounds have immature lungs that often require high levels of ventilation oxygen in the hospital. This contributes to the chronic lung disease ...

Please provide your email address to receive an email when new articles are posted on . Ciliary beat frequency in neonates with mild bronchopulmonary dysplasia (BPD) significantly differed vs.

ATLANTA--(BUSINESS WIRE)--Airway Therapeutics, Inc. (Airway), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with ...

ATLANTA--(BUSINESS WIRE)--Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and ...

Overuse of antibiotics early in life may increase the risk for bronchopulmonary dysplasia (BPD) or mortality in very premature infants, a national cohort study from China found. Among 6,510 such ...